nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—Local reaction—Octreotide—thymus cancer	0.04	0.0488	CcSEcCtD
Midazolam—Fracture—Octreotide—thymus cancer	0.0381	0.0465	CcSEcCtD
Midazolam—Multiple fractures—Octreotide—thymus cancer	0.0381	0.0465	CcSEcCtD
Midazolam—Haematoma—Octreotide—thymus cancer	0.0353	0.043	CcSEcCtD
Midazolam—Redness—Octreotide—thymus cancer	0.0328	0.04	CcSEcCtD
Midazolam—Injection site pain—Octreotide—thymus cancer	0.0272	0.0331	CcSEcCtD
Midazolam—Muscle twitching—Octreotide—thymus cancer	0.0226	0.0275	CcSEcCtD
Midazolam—Wheezing—Octreotide—thymus cancer	0.0215	0.0262	CcSEcCtD
Midazolam—Hyperkinesia—Octreotide—thymus cancer	0.0193	0.0236	CcSEcCtD
Midazolam—Phlebitis—Octreotide—thymus cancer	0.0187	0.0228	CcSEcCtD
Midazolam—Sleep disorder—Octreotide—thymus cancer	0.0186	0.0227	CcSEcCtD
Midazolam—Thrombophlebitis—Octreotide—thymus cancer	0.0186	0.0227	CcSEcCtD
Midazolam—Injury—Octreotide—thymus cancer	0.0175	0.0213	CcSEcCtD
Midazolam—Visual disturbance—Octreotide—thymus cancer	0.017	0.0207	CcSEcCtD
Midazolam—Anaphylactoid reaction—Octreotide—thymus cancer	0.0166	0.0203	CcSEcCtD
Midazolam—Osteoarthritis—Octreotide—thymus cancer	0.0161	0.0196	CcSEcCtD
Midazolam—Psychotic disorder—Octreotide—thymus cancer	0.0157	0.0192	CcSEcCtD
Midazolam—Irritability—Octreotide—thymus cancer	0.0154	0.0187	CcSEcCtD
Midazolam—Nasopharyngitis—Octreotide—thymus cancer	0.0144	0.0175	CcSEcCtD
Midazolam—Muscular weakness—Octreotide—thymus cancer	0.0142	0.0173	CcSEcCtD
Midazolam—UGT1A4—hematopoietic system—thymus cancer	0.0137	0.0764	CbGeAlD
Midazolam—Bronchospasm—Octreotide—thymus cancer	0.0137	0.0167	CcSEcCtD
Midazolam—Drowsiness—Octreotide—thymus cancer	0.0124	0.0151	CcSEcCtD
Midazolam—Depression—Octreotide—thymus cancer	0.0124	0.0151	CcSEcCtD
Midazolam—Neuropathy peripheral—Octreotide—thymus cancer	0.0122	0.0148	CcSEcCtD
Midazolam—Bradycardia—Octreotide—thymus cancer	0.0113	0.0138	CcSEcCtD
Midazolam—Visual impairment—Octreotide—thymus cancer	0.0107	0.0131	CcSEcCtD
Midazolam—GABRA3—neck—thymus cancer	0.0106	0.059	CbGeAlD
Midazolam—Cardiac disorder—Octreotide—thymus cancer	0.0103	0.0126	CcSEcCtD
Midazolam—CYP4B1—cardiac atrium—thymus cancer	0.0103	0.0573	CbGeAlD
Midazolam—Immune system disorder—Octreotide—thymus cancer	0.0101	0.0123	CcSEcCtD
Midazolam—CYP4B1—pituitary gland—thymus cancer	0.01	0.0559	CbGeAlD
Midazolam—Mental disorder—Octreotide—thymus cancer	0.00975	0.0119	CcSEcCtD
Midazolam—Erythema—Octreotide—thymus cancer	0.00969	0.0118	CcSEcCtD
Midazolam—Tension—Octreotide—thymus cancer	0.00951	0.0116	CcSEcCtD
Midazolam—Nervousness—Octreotide—thymus cancer	0.00941	0.0115	CcSEcCtD
Midazolam—Vision blurred—Octreotide—thymus cancer	0.00913	0.0111	CcSEcCtD
Midazolam—Tremor—Octreotide—thymus cancer	0.00908	0.0111	CcSEcCtD
Midazolam—Agitation—Octreotide—thymus cancer	0.00891	0.0109	CcSEcCtD
Midazolam—Vertigo—Octreotide—thymus cancer	0.00871	0.0106	CcSEcCtD
Midazolam—Syncope—Octreotide—thymus cancer	0.00869	0.0106	CcSEcCtD
Midazolam—CYP4B1—thyroid gland—thymus cancer	0.00866	0.0482	CbGeAlD
Midazolam—Cough—Octreotide—thymus cancer	0.00846	0.0103	CcSEcCtD
Midazolam—Anxiety—Octreotide—thymus cancer	0.00822	0.01	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00819	0.00999	CcSEcCtD
Midazolam—GABRG3—pituitary gland—thymus cancer	0.00816	0.0455	CbGeAlD
Midazolam—Dry mouth—Octreotide—thymus cancer	0.00807	0.00983	CcSEcCtD
Midazolam—Anaphylactic shock—Octreotide—thymus cancer	0.00791	0.00964	CcSEcCtD
Midazolam—CYP4B1—lung—thymus cancer	0.00786	0.0438	CbGeAlD
Midazolam—Shock—Octreotide—thymus cancer	0.00778	0.00948	CcSEcCtD
Midazolam—Nervous system disorder—Octreotide—thymus cancer	0.00776	0.00945	CcSEcCtD
Midazolam—Tachycardia—Octreotide—thymus cancer	0.00772	0.00941	CcSEcCtD
Midazolam—Skin disorder—Octreotide—thymus cancer	0.00768	0.00936	CcSEcCtD
Midazolam—Paraesthesia—Octreotide—thymus cancer	0.0071	0.00865	CcSEcCtD
Midazolam—Dyspnoea—Octreotide—thymus cancer	0.00705	0.00859	CcSEcCtD
Midazolam—Somnolence—Octreotide—thymus cancer	0.00703	0.00857	CcSEcCtD
Midazolam—Dyspepsia—Octreotide—thymus cancer	0.00696	0.00848	CcSEcCtD
Midazolam—Gastrointestinal disorder—Octreotide—thymus cancer	0.00683	0.00832	CcSEcCtD
Midazolam—Fatigue—Octreotide—thymus cancer	0.00682	0.00831	CcSEcCtD
Midazolam—Pain—Octreotide—thymus cancer	0.00676	0.00824	CcSEcCtD
Midazolam—Constipation—Octreotide—thymus cancer	0.00676	0.00824	CcSEcCtD
Midazolam—Feeling abnormal—Octreotide—thymus cancer	0.00652	0.00794	CcSEcCtD
Midazolam—GABRB1—pituitary gland—thymus cancer	0.00631	0.0352	CbGeAlD
Midazolam—Urticaria—Octreotide—thymus cancer	0.00628	0.00766	CcSEcCtD
Midazolam—Hypersensitivity—Octreotide—thymus cancer	0.00583	0.0071	CcSEcCtD
Midazolam—GABRA4—pituitary gland—thymus cancer	0.00569	0.0317	CbGeAlD
Midazolam—Asthenia—Octreotide—thymus cancer	0.00567	0.00692	CcSEcCtD
Midazolam—GABRP—pituitary gland—thymus cancer	0.00565	0.0315	CbGeAlD
Midazolam—Pruritus—Octreotide—thymus cancer	0.0056	0.00682	CcSEcCtD
Midazolam—CYP4B1—lymph node—thymus cancer	0.00538	0.03	CbGeAlD
Midazolam—Dizziness—Octreotide—thymus cancer	0.00523	0.00637	CcSEcCtD
Midazolam—GABRA3—thyroid gland—thymus cancer	0.00504	0.0281	CbGeAlD
Midazolam—Vomiting—Octreotide—thymus cancer	0.00503	0.00613	CcSEcCtD
Midazolam—Rash—Octreotide—thymus cancer	0.00499	0.00608	CcSEcCtD
Midazolam—Dermatitis—Octreotide—thymus cancer	0.00498	0.00607	CcSEcCtD
Midazolam—Headache—Octreotide—thymus cancer	0.00495	0.00604	CcSEcCtD
Midazolam—GABRG2—pituitary gland—thymus cancer	0.00476	0.0265	CbGeAlD
Midazolam—Nausea—Octreotide—thymus cancer	0.0047	0.00573	CcSEcCtD
Midazolam—GABRP—lung—thymus cancer	0.00443	0.0247	CbGeAlD
Midazolam—GABRE—cardiac atrium—thymus cancer	0.00442	0.0246	CbGeAlD
Midazolam—GABRR2—lymph node—thymus cancer	0.00433	0.0241	CbGeAlD
Midazolam—GABRE—pituitary gland—thymus cancer	0.00432	0.024	CbGeAlD
Midazolam—GABRB2—lung—thymus cancer	0.00373	0.0208	CbGeAlD
Midazolam—GABRE—thyroid gland—thymus cancer	0.00372	0.0207	CbGeAlD
Midazolam—GABRB3—pituitary gland—thymus cancer	0.00366	0.0204	CbGeAlD
Midazolam—GABRE—lung—thymus cancer	0.00338	0.0188	CbGeAlD
Midazolam—CYP3A5—hematopoietic system—thymus cancer	0.00336	0.0187	CbGeAlD
Midazolam—CYP2B6—hematopoietic system—thymus cancer	0.00334	0.0186	CbGeAlD
Midazolam—GABRB3—thyroid gland—thymus cancer	0.00315	0.0176	CbGeAlD
Midazolam—CYP2E1—hematopoietic system—thymus cancer	0.00314	0.0175	CbGeAlD
Midazolam—GABRB3—lung—thymus cancer	0.00286	0.016	CbGeAlD
Midazolam—CYP3A4—hematopoietic system—thymus cancer	0.00252	0.0141	CbGeAlD
Midazolam—CYP2B6—lymphoid tissue—thymus cancer	0.00235	0.0131	CbGeAlD
Midazolam—GABRA2—lymph node—thymus cancer	0.00233	0.013	CbGeAlD
Midazolam—GABRE—lymph node—thymus cancer	0.00231	0.0129	CbGeAlD
Midazolam—CYP2E1—lymphoid tissue—thymus cancer	0.00221	0.0123	CbGeAlD
Midazolam—CYP2E1—thyroid gland—thymus cancer	0.00201	0.0112	CbGeAlD
Midazolam—CYP3A5—lung—thymus cancer	0.00195	0.0109	CbGeAlD
Midazolam—CYP2B6—lung—thymus cancer	0.00194	0.0108	CbGeAlD
Midazolam—CYP2E1—lung—thymus cancer	0.00182	0.0102	CbGeAlD
Midazolam—ABCB1—hematopoietic system—thymus cancer	0.00179	0.00996	CbGeAlD
Midazolam—ABCB1—epithelium—thymus cancer	0.00163	0.0091	CbGeAlD
Midazolam—ABCB1—pituitary gland—thymus cancer	0.00133	0.00739	CbGeAlD
Midazolam—ABCB1—lymphoid tissue—thymus cancer	0.00126	0.00701	CbGeAlD
Midazolam—ABCB1—bone marrow—thymus cancer	0.00115	0.00638	CbGeAlD
Midazolam—ABCB1—thyroid gland—thymus cancer	0.00114	0.00637	CbGeAlD
Midazolam—ABCB1—lung—thymus cancer	0.00104	0.00578	CbGeAlD
Midazolam—ABCB1—lymph node—thymus cancer	0.00071	0.00395	CbGeAlD
